PharmiWeb10h
Leaps by Bayer Announces One of the Largest Global Surveys of Society’s Attitudes Toward Breakthrough Technologies
The data uncover broad optimism as well as stark regional disparities and cultural obstacles in the West that must be ...
How High-Growth Leaders Can Capitalize On Self-Directed Work Teams
Self-managed teams democratize the world of work by empowering employees. With management ranks flattening, high-growth ...
Global Radiopharmaceuticals Market is expected to reach revenue of USD 9,876.2 Mn by 2033, at 3.5% CAGR: Dimension Market Research.
Advancements and Projections in the Global Radiopharmaceuticals Market: Insights, Trends, Opportunities, and Recent ...
How Martin Luther King Jr.’s Vision Resonates With Today’s Changing Environment
King in those last days of his life was speaking to how the environment and the conditions in which people live and work ...
pharmaphorum20h
Bayer props up sagging radionuclide business with Noria acquisition
The technology behind the drug was licensed from Weill Cornell Medicine and Johns Hopkins University in the US. It's worth noting that Bayer has its own PSMA-targeting thorium-227 drug – BAY ...
Medscape20h
Room-temperature Storage of Medications Labeled for Refrigeration
Hyperhep B S/D (Bayer) Cumulative exposure for 7 days Manufacturer Hepatitis B vaccine (recombinant) Engerix-B (GlaxoSmithKline) 72 hr Manufacturer Immune globulin (human) Gamastan S/D (Bayer ...
Multivitamin Gummy Market To Reach USD 7.3 Billion By 2034, Growing At A CAGR Of 5.4% Future Market Insights, Inc.
Multivitamin Gummies Market Regional Analysis of Multivitamin Gummies Market The UK multivitamin gummy <a target=_blank href=http ...
pharmaphorum20h
Sanofi claims FDA okay for drug to treat rare blood disorder CAD
Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US. The ...